{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:14:52Z","timestamp":1769768092026,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T00:00:00Z","timestamp":1388361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T00:00:00Z","timestamp":1388361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Although the survival rates of hematological patients admitted to the ICU are improving, little is known about the long-term outcome. Our objective was to identify factors related to long-term outcome in hematological patients after ICU discharge.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A prospective, observational study was carried out in seven centers in Spain. From an initial sample of 161 hematological patients admitted to one of the participating ICUs during the study period, 62 were discharged alive and followed for a median time of 23 (1 to 54) months. Univariate and multivariate analysis were performed to identify the factors related to long term-survival. Finally, variables that influence the continuation of the scheduled therapy for the hematological disease were studied.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Mortality after ICU discharge was 61%, with a median survival of 18 (1 to 54) months. In the multivariate analysis, an Eastern Cooperative Oncology Group score (ECOG) &gt;2 at ICU discharge (Hazard ratio 11.15 (4.626 to 26.872)), relapse of the hematological disease (Hazard ratio 9.738 (3.804 to 24.93)) and discontinuation of the planned treatment for the hematological disease (Hazard ratio 4.349 (1.286 to 14.705)) were independently related to mortality. Absence of stem cell transplantation, high ECOG and high Acute Physiology and Chronic Health Evaluation II (APACHE II) scores decreased the probability of receiving the planned therapy for the hematological malignancy.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Both ICU care and post-ICU management determine the long-term outcome of hematological patients who are discharged alive from the ICU.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc13172","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T18:01:26Z","timestamp":1388426486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Survival of hematological patients after discharge from the intensive care unit: a prospective observational study"],"prefix":"10.1186","volume":"17","author":[{"given":"Teresa","family":"Bernal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefan\u00eda V","family":"Pardavila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Bonastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Bargay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ignacio","family":"Ayestar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josu","family":"Insausti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Gonz\u00e1lez-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Mart\u00ednez-Camblor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo M","family":"Albaiceta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"3062_CR1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1183\/09031936.00142907","volume":"32","author":"L Lecuyer","year":"2008","unstructured":"Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B, Azoulay E: Case volume and mortality in haematological patients with acute respiratory failure.\n                           Eur Respir J 2008, 32: 748-754. 10.1183\/09031936.00142907","journal-title":"Eur Respir J"},{"key":"3062_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00003246-200103000-00009","volume":"29","author":"E Azoulay","year":"2001","unstructured":"Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B: Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support.\n                           Crit Care Med 2001, 29: 519-525. 10.1097\/00003246-200103000-00009","journal-title":"Crit Care Med"},{"key":"3062_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","volume":"40","author":"M Legrand","year":"2012","unstructured":"Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A, Lemiale V, Seguin A, Darmon M, Schlemmer B, Azoulay E: Survival in neutropenic patients with severe sepsis or septic shock.\n                           Crit Care Med 2012, 40: 43-49. 10.1097\/CCM.0b013e31822b50c2","journal-title":"Crit Care Med"},{"key":"3062_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/10428190903456959","volume":"51","author":"M Darmon","year":"2010","unstructured":"Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E: Prognostic significance of acute renal injury in acute tumor lysis syndrome.\n                           Leuk Lymphoma 2010, 51: 221-227. 10.3109\/10428190903456959","journal-title":"Leuk Lymphoma"},{"key":"3062_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00134-002-1420-5","volume":"28","author":"F Kroschinsky","year":"2002","unstructured":"Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, Ehninger G, Schuler U: Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies.\n                           Intensive Care Med 2002, 28: 1294-1300. 10.1007\/s00134-002-1420-5","journal-title":"Intensive Care Med"},{"key":"3062_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1378\/chest.08-0359","volume":"134","author":"M Soares","year":"2008","unstructured":"Soares M, Salluh JI, Torres VB, Leal JV, Spector N: Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay.\n                           Chest 2008, 134: 520-526. 10.1378\/chest.08-0359","journal-title":"Chest"},{"key":"3062_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2141.2005.05459.x","volume":"129","author":"A Rabbat","year":"2005","unstructured":"Rabbat A, Chaoui D, Montani D, Legrand O, Lefebvre A, Rio B, Roche N, Lorut C, Marie JP, Huchon G: Prognosis of patients with acute myeloid leukaemia admitted to intensive care.\n                           Br J Haematol 2005, 129: 350-357. 10.1111\/j.1365-2141.2005.05459.x","journal-title":"Br J Haematol"},{"key":"3062_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1200\/JCO.2005.03.9073","volume":"24","author":"F Pene","year":"2006","unstructured":"Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Socie G, Mira JP: Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.\n                           J Clin Oncol 2006, 24: 643-649. 10.1200\/JCO.2005.03.9073","journal-title":"J Clin Oncol"},{"key":"3062_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00134-012-2791-x","volume":"39","author":"SG Oeyen","year":"2013","unstructured":"Oeyen SG, Benoit DD, Annemans L, Depuydt PO, Van Belle SJ, Troisi RI, Noens LA, Pattyn P, Decruyenaere JM: Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.\n                           Intensive Care Med 2013, 39: 889-898. 10.1007\/s00134-012-2791-x","journal-title":"Intensive Care Med"},{"key":"3062_CR10","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V: Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from france and belgium\u2013a groupe de recherche respiratoire en reanimation onco-hematologique study.\n                           J Clin Oncol 2013, 31: 2810-2818. 10.1200\/JCO.2012.47.2365","journal-title":"J Clin Oncol"},{"key":"3062_CR11","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/cc11438","volume":"16","author":"R Molina","year":"2012","unstructured":"Molina R, Bernal T, Borges M, Zaragoza R, Bonastre J, Granada RM, Rodriguez-Borregan JC, Nunez K, Seijas I, Ayestaran I, Albaiceta GM: Ventilatory support in critically ill hematology patients with respiratory failure.\n                           Crit Care 2012, 16: R133. 10.1186\/cc11438","journal-title":"Crit Care"},{"key":"3062_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.\n                           Clin Infect Dis 2002, 34: 730-751. 10.1086\/339215","journal-title":"Clin Infect Dis"},{"key":"3062_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group.\n                           Am J Clin Oncol 1982, 5: 649-655. 10.1097\/00000421-198212000-00014","journal-title":"Am J Clin Oncol"},{"key":"3062_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y: Survival model predictive accuracy and ROC curves.\n                           Biometrics 2005, 61: 92-105. 10.1111\/j.0006-341X.2005.030814.x","journal-title":"Biometrics"},{"key":"3062_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.CCM.0000256846.27192.7A","volume":"35","author":"L Lecuyer","year":"2007","unstructured":"Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E: The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation.\n                           Crit Care Med 2007, 35: 808-814. 10.1097\/01.CCM.0000256846.27192.7A","journal-title":"Crit Care Med"},{"key":"3062_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/CCO.0b013e32832b68b6","volume":"21","author":"M Darmon","year":"2009","unstructured":"Darmon M, Azoulay E: Critical care management of cancer patients: cause for optimism and need for objectivity.\n                           Curr Opin Oncol 2009, 21: 318-326. 10.1097\/CCO.0b013e32832b68b6","journal-title":"Curr Opin Oncol"},{"key":"3062_CR17","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/cc6921","volume":"12","author":"TM Merz","year":"2008","unstructured":"Merz TM, Schar P, Buhlmann M, Takala J, Rothen HU: Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study.\n                           Crit Care 2008, 12: R75. 10.1186\/cc6921","journal-title":"Crit Care"},{"key":"3062_CR18","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1097\/00003246-200210000-00014","volume":"30","author":"PB Massion","year":"2002","unstructured":"Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installe E: Prognosis of hematologic malignancies does not predict intensive care unit mortality.\n                           Crit Care Med 2002, 30: 2260-2270. 10.1097\/00003246-200210000-00014","journal-title":"Crit Care Med"},{"key":"3062_CR19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jama.2010.216","volume":"303","author":"H Wunsch","year":"2010","unstructured":"Wunsch H, Guerra C, Barnato AE, Angus DC, Li G, Linde-Zwirble WT: Three-year outcomes for Medicare beneficiaries who survive intensive care.\n                           JAMA 2010, 303: 849-856. 10.1001\/jama.2010.216","journal-title":"JAMA"},{"key":"3062_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, Gachot B, Heinz WJ, Lass-Florl C, Ribaud P, Thiebaut A, Cordonnier C: European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update.\n                           Bone Marrow Transplant 2011, 46: 709-718. 10.1038\/bmt.2010.175","journal-title":"Bone Marrow Transplant"},{"key":"3062_CR21","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2012.47.4874","volume":"31","author":"AK Burnett","year":"2013","unstructured":"Burnett AK, Russell NH, Hills RK, Hunter AE, Kjeldsen L, Yin J, Gibson BE, Wheatley K, Milligan D: Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the Medical Research Council AML15 trial.\n                           J Clin Oncol 2013, 31: 3360-3368. 10.1200\/JCO.2012.47.4874","journal-title":"J Clin Oncol"},{"key":"3062_CR22","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project\n                           N Engl J Med 1993, 329: 987-994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"3062_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wormann B, Ludwig WD, Duhrsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M: A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.\n                           Blood 2008, 111: 558-565. 10.1182\/blood-2007-06-095331","journal-title":"Blood"},{"key":"3062_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1200\/JCO.2011.40.3642","volume":"31","author":"C Gardin","year":"2013","unstructured":"Gardin C, Chevret S, Pautas C, Turlure P, Raffoux E, Thomas X, Quesnel B, de Revel T, de Botton S, Gachard N, Renneville A, Boissel N, Preudhomme C, Terre C, Fenaux P, Bordessoule D, Celli-Lebras K, Castaigne S, Dombret H: Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.\n                           J Clin Oncol 2013, 31: 321-327. 10.1200\/JCO.2011.40.3642","journal-title":"J Clin Oncol"},{"key":"3062_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bmt.1704379","volume":"33","author":"M Gomez-Nunez","year":"2004","unstructured":"Gomez-Nunez M, Martino R, Caballero MD, Perez-Simon JA, Canals C, Mateos MV, Sarra J, Leon A, Solano C, Moraleda JM, Urbano-Ispizua A, Besalduch J, Miguel JS, Sierra J: Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial.\n                           Bone Marrow Transplant 2004, 33: 477-482. 10.1038\/sj.bmt.1704379","journal-title":"Bone Marrow Transplant"},{"key":"3062_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1182\/blood-2012-08-234492","volume":"121","author":"SJ Forman","year":"2013","unstructured":"Forman SJ, Rowe JM: The myth of the second remission of acute leukemia in the adult.\n                           Blood 2013, 121: 1077-1082. 10.1182\/blood-2012-08-234492","journal-title":"Blood"},{"key":"3062_CR27","doi-asserted-by":"publisher","first-page":"S410","DOI":"10.1097\/CCM.0b013e3181b6e28b","volume":"37","author":"L Brochard","year":"2009","unstructured":"Brochard L, Thille AW: What is the proper approach to liberating the weak from mechanical ventilation?\n                           Crit Care Med 2009, 37: S410-S415.","journal-title":"Crit Care Med"},{"key":"3062_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-008-1320-4","volume":"35","author":"V Peigne","year":"2009","unstructured":"Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E: Continued survival gains in recent years among critically ill myeloma patients.\n                           Intensive Care Med 2009, 35: 512-518. 10.1007\/s00134-008-1320-4","journal-title":"Intensive Care Med"},{"key":"3062_CR29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2407-10-516","volume":"10","author":"R d Ordons AL","year":"2010","unstructured":"Ordons AL R d, Chan K, Mirza I, Townsend DR, Bagshaw SM: Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case\u2013control study.\n                           BMC cancer 2010, 10: 516.","journal-title":"BMC cancer"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc13172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc13172\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc13172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:19:15Z","timestamp":1728382755000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc13172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,30]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["3062"],"URL":"https:\/\/doi.org\/10.1186\/cc13172","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,30]]},"assertion":[{"value":"19 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R302"}}